ADVANTAGE

Home » Advantage

0

Square Meter

0

+ Staff

0

+ R&D Staff

0

Established

Best Facilities

MDI & Spray Plant was established in 2002, dedicated to the production of inhalation aerosol and spray. This plant has five automatic MDI filling lines introduced from Pamasol, Switzerland and Italy automatic lines for assembly, spray testing and online weight double-checking machines. The annual capacity can achieve 60 million packs. The plant has passed TGA GMP certification for three times with the highest level A1.

Two-Step Filling Line
One-Step Filling Line
Assembly Line

Jewim Multi-Dosage Form Plant was founded in 2004, covering an area of about 130000 m², mainly produces sterile inhalation solution, dry powder inhalation (DPI), solid preparation, liquid preparation, small volume parenteral (SVP) and API, etc. Jewim introduced international advanced production equipment, including: Switzerland Rommelag BFS (three-in-one) machine, German Harro Hoefliger DPI filling machine, German GEA high-speed blender, German Glatt granulator, IMA capsule filling machine, tablet compression machine and other international top equipments to improve the production capacity, meet the requirements of data integrity and traceability, improve production efficiency and quality control level, as well as minimize errors and pollution caused by human operation.

Since the launch and continuous improvement of Oracle ERP in December 2006, we have completed the informatization management of manufacturing and production organizations to respond to market changes in real time and practice the "customer-centric" value concept.

Switzerland Rommelag BFS Three-in-one Machine
German Harro Hoefliger DPIs Filling Machine
German Harro Hoefliger DPIs Filling Machine
German Glatt Granulator
Tablet Compression Machine
API Workshop

Professional R & D Team

Jewim has a professional R&D team with more than 300 people led by a chief scientist with over 20 years R&D experience in pharmaceutical MNC and more than 70% of the team has doctoral or master degrees. Jewim's annual research and development investment accounts for 10-15% of sales revenue.

Jewim has a dedicated R&D center and the area exceeds 10,000 m², equipped with world-leading equipment and analytical instruments, it can undertake the whole activities of drug development from lab research to commercial scale production.

Open innovation and strategic cooperation are the keys to successful drug development, and the company maintains cooperation with research institutions in China and overseas to accelerate the pace of transformation to innovation.

High Level QMS

We aim to achieve customer satisfaction by consistently meeting regulatory and customer requirements. Effective operating of PQS is the assurance of the products safety and effectiveness, as well as the key to success.
Medicines are related to people's lives, and the quality of medicines is the belief and life of every Jewim employee. Jewim adheres to the social responsibility of "pursuing the truth, goodness and beauty of pharmaceutical production", and continuously improves the international level of the production quality system. The company's quality system has passed TGA certification with the highest standard A1 level three times, and has passed GMP and GLP certifications in more than 20 overseas countries. Jewim’s quality system is also supported and recognized by its strategic partner Johnson & Johnson.

ADVANTAGE

Best Facilities

Professional R & D Team

High Level QMS

QUICK LINKS

CATEGORIES